{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T04:54:58Z","timestamp":1764996898940},"reference-count":19,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.neurobiolaging.2010.11.023","type":"journal-article","created":{"date-parts":[[2011,1,13]],"date-time":"2011-01-13T09:20:47Z","timestamp":1294910447000},"page":"756.e1-756.e9","source":"Crossref","is-referenced-by-count":8,"title":["Genetic prion disease with codon 196 PRNP mutation: clinical and pathological findings"],"prefix":"10.1016","volume":"32","author":[{"given":"Gabi","family":"Schelzke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabina","family":"Eigenbrod","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Romero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Varges","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maren","family":"Breithaupt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana L.","family":"Taratuto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans A.","family":"Kretzschmar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inga","family":"Zerr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2010.11.023_bib1","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/S0140-6736(99)01342-2","article-title":"Codon 129 prion protein genotype and sporadic Creutzfeldt-Jakob disease","volume":"353","author":"Alperovitch","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.neurobiolaging.2010.11.023_bib2","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.clineuro.2009.11.002","article-title":"Rare E196K mutation in the PRNP gene of a patient exhibiting behavioral abnormalities","volume":"112","author":"Bejot","year":"2010","journal-title":"Clin. Neurol. Neurosurg"},{"key":"10.1016\/j.neurobiolaging.2010.11.023_bib3","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jns.2008.06.036","article-title":"Atypical presentation of Creutzfeldt-Jakob disease: the first Italian case associated with E196K mutation in the PRNP gene","volume":"275","author":"Clerici","year":"2008","journal-title":"J. Neurol. Sci"},{"key":"10.1016\/j.neurobiolaging.2010.11.023_bib4","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/s00401-004-0913-4","article-title":"Loss of glycosylation associated with the T183A mutation in human prion disease","volume":"108","author":"Grasbon-Frodl","year":"2004","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neurobiolaging.2010.11.023_bib5","first-page":"1285","article-title":"Abnormal isoform of prion proteins accumulates in the synaptic structures of the central nervous system in patients with Creutzfeldt\u2013Jakob disease","volume":"140","author":"Kitamoto","year":"1992","journal-title":"Am. J. Pathol"},{"key":"10.1016\/j.neurobiolaging.2010.11.023_bib6","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s00439-005-0020-1","article-title":"Genetic prion disease: the EUROCJD experience","volume":"118","author":"Kovacs","year":"2005","journal-title":"Hum. Genet"},{"key":"10.1016\/j.neurobiolaging.2010.11.023_bib7","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1001\/archneur.1996.00550090125018","article-title":"Diagnostic criteria for sporadic Creutzfeldt\u2013Jakob disease","volume":"53","author":"Kretzschmar","year":"1996","journal-title":"Arch. Neurol"},{"key":"10.1016\/j.neurobiolaging.2010.11.023_bib8","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1212\/WNL.0b013e3181a96e5d","article-title":"MRI lesion profiles in sporadic Creutzfeldt-Jakob disease","volume":"72","author":"Meissner","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2010.11.023_bib9","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W","article-title":"Classification of sporadic Creutzfeldt\u2013Jakob disease based on molecular and phenotypic analysis of 300 subjects","volume":"46","author":"Parchi","year":"1999","journal-title":"Ann. Neurol"},{"key":"10.1016\/j.neurobiolaging.2010.11.023_bib10","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/(SICI)1098-1004(200005)15:5<482::AID-HUMU16>3.0.CO;2-1","article-title":"Identification of three novel mutations (E196K, V203I, E211Q) in the prion protein gene (PRNP) in inherited prion diseases with Creutzfeldt-Jakob disease phenotype","volume":"15","author":"Peoc'h","year":"2000","journal-title":"Hum. Mutat"},{"key":"10.1016\/j.neurobiolaging.2010.11.023_bib11a","first-page":"25","article-title":"Moleculargenetic determination of the disease phenotype in sporadic Creutzfeldt\u2013Jakob disease","volume":"28","author":"Schulz-Schaeffer","year":"2000","journal-title":"Infection"},{"key":"10.1016\/j.neurobiolaging.2010.11.023_bib11","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0002-9440(10)64705-0","article-title":"The paraffin-embedded tissue blot detects PrP(Sc) early in the incubation time in prion diseases","volume":"156","author":"Schulz-Schaeffer","year":"2000","journal-title":"Am. J. Pathol"},{"key":"10.1016\/j.neurobiolaging.2010.11.023_bib13","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1001\/archneur.1996.00550020074017","article-title":"Accuracy and reliability of periodic sharp wave complexes in Creutzfeldt\u2013Jakob disease","volume":"53","author":"Steinhoff","year":"1996","journal-title":"Arch. Neurol"},{"key":"10.1016\/j.neurobiolaging.2010.11.023_bib14","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1055\/s-2002-20148","article-title":"Clinically atypical CJD: diagnostic relevance of cerebrospinal fluid markers and molecular genetic analysis?","volume":"127","author":"Tumani","year":"2002","journal-title":"Dtsch. Med. Wochenschr"},{"key":"10.1016\/j.neurobiolaging.2010.11.023_bib15","first-page":"361","article-title":"Human transmissible spongiform encephalopathies","volume":"47","year":"1998","journal-title":"Wkly. Epidemiol. Rec"},{"key":"10.1016\/j.neurobiolaging.2010.11.023_bib16","first-page":"244","article-title":"Molecular genetics of human prion diseases in Germany","volume":"105","author":"Windl","year":"1999","journal-title":"Genet"},{"key":"10.1016\/j.neurobiolaging.2010.11.023_bib17","first-page":"32","article-title":"Detection of 14\u20133-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt\u2013Jakob disease","volume":"43","author":"Zerr","year":"1998","journal-title":"Neurol"},{"key":"10.1016\/j.neurobiolaging.2010.11.023_bib18","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1093\/brain\/awp191","article-title":"Updated clinical diagnostic criteria for sporadic Creutzfeldt\u2013Jakob disease","volume":"132","author":"Zerr","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2010.11.023_bib19","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1212\/WNL.55.6.811","article-title":"Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease","volume":"55","author":"Zerr","year":"2000","journal-title":"Neurology"}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458010005166?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458010005166?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,5]],"date-time":"2018-12-05T15:24:14Z","timestamp":1544023454000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458010005166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S0197458010005166"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2010.11.023","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}